4
45fan
Greetings from a new user. This is my first post. I've been reading and using info from this site for a while. Truly a blessing to the industry. I must thank Marc for starting and maintaining this site and all of the participants for the helpful and sometimes entertaining posts.
I am currently setting up a quality system for a new medical device firm and planning clinical trials in Europe, Italy to be exact. The quality system is about 25% and I've been asked how soon we can do some clinicals.
I have a few questions for starters.
1. Is anyone aware what is the "competent authority" in Italy?
2. The MDD does not explicitly require quality systems compliance for clinical investigations, but does imply such in Annex VIII, along with requiring consent to assessment, or audit where necessary, that manufacturing processes and controls produce product to spec. Sounds like a QS to me. Am I reading this right, or too much? Or do I need to consult the Italian authorities and the hospital before I determine how complete my QS needs to be?
Best regards,
Tom
I am currently setting up a quality system for a new medical device firm and planning clinical trials in Europe, Italy to be exact. The quality system is about 25% and I've been asked how soon we can do some clinicals.
I have a few questions for starters.
1. Is anyone aware what is the "competent authority" in Italy?
2. The MDD does not explicitly require quality systems compliance for clinical investigations, but does imply such in Annex VIII, along with requiring consent to assessment, or audit where necessary, that manufacturing processes and controls produce product to spec. Sounds like a QS to me. Am I reading this right, or too much? Or do I need to consult the Italian authorities and the hospital before I determine how complete my QS needs to be?
Best regards,
Tom
Last edited by a moderator: